Glockenblume bestechen Deutung nf kappa b pubmed Perth Blackborough Pelz Plakat
NF-κB in the New Era of Cancer Therapy: Trends in Cancer
NF-κB, a culprit of both inflamm-ageing and declining immunity? | Immunity & Ageing | Full Text
Frontiers | Nuclear Factor-kappaB in Autoimmunity: Man and Mouse
Suppression of NF-κB and NF-κB-Regulated Gene Expression by Apigenin through IκBα and IKK Pathway in TRAMP Mice | PLOS ONE
NF-κB and Extrinsic Cell Death Pathways – Entwined Do-or-Die Decisions for T cells: Trends in Immunology
Frontiers | The NF-κB Signaling Pathway, the Microbiota, and Gastrointestinal Tumorigenesis: Recent Advances
LRRC25 Functions as an Inhibitor of NF-κB Signaling Pathway by Promoting p65/RelA for Autophagic Degradation | Scientific Reports
Cells | Free Full-Text | The Ubiquitination of NF-κB Subunits in the Control of Transcription
NF-κB signaling in inflammation | Signal Transduction and Targeted Therapy
NF-κB p65 and p105 implicate in interleukin 1β-mediated COX-2 expression in melanoma cells | PLOS ONE
NF-κB, inflammation, immunity and cancer: coming of age | Nature Reviews Immunology
Cancers | Free Full-Text | NF-kappa B Signaling-Related Signatures Are Connected with the Mesenchymal Phenotype of Circulating Tumor Cells in Non-Metastatic Breast Cancer
Frontiers | Nuclear Factor κB (NF-κB)–Mediated Inflammation in Multiple Sclerosis
Frontiers | What Is Nuclear Factor Kappa B (NF-κB) Doing in and to the Mitochondrion?
Frontiers | NF-κB Signaling in Macrophages: Dynamics, Crosstalk, and Signal Integration
Frontiers | NF-κB Regulation by Gut Microbiota Decides Homeostasis or Disease Outcome During Ageing
Cancers | Free Full-Text | Context-Dependent Role of NF-κB Signaling in Primary Liver Cancer—from Tumor Development to Therapeutic Implications
Noncanonical NF-κB Signaling Pathway in Liver Diseases
Frontiers | Primate Lentiviruses Modulate NF-κB Activity by Multiple Mechanisms to Fine-Tune Viral and Cellular Gene Expression
NF-κB signaling pathways regulated by CARMA family of scaffold proteins | Cell Research
Targeting NF-κB pathway for the therapy of diseases: mechanism and clinical study | Signal Transduction and Targeted Therapy
Nuclear factor kappa B activation appears weaker in schizophrenia patients with high brain cytokines than in non-schizophrenic controls with high brain cytokines | Journal of Neuroinflammation | Full Text